1. Loukinov, Dmitri. 2018. Targeting CTCFL/BORIS for the immunotherapy of cancer. In Cancer immunology, immunotherapy : CII, 67, 1955-1965. doi:10.1007/s00262-018-2251-8. https://pubmed.ncbi.nlm.nih.gov/30390146/
2. Sleutels, Frank, Soochit, Widia, Bartkuhn, Marek, Grosveld, Frank, Galjart, Niels. 2012. The male germ cell gene regulator CTCFL is functionally different from CTCF and binds CTCF-like consensus sites in a nucleosome composition-dependent manner. In Epigenetics & chromatin, 5, 8. doi:10.1186/1756-8935-5-8. https://pubmed.ncbi.nlm.nih.gov/22709888/
3. Sati, Leyla, Zeiss, Caroline, Yekkala, Krishna, Demir, Ramazan, McGrath, James. 2015. Expression of the CTCFL Gene during Mouse Embryogenesis Causes Growth Retardation, Postnatal Lethality, and Dysregulation of the Transforming Growth Factor β Pathway. In Molecular and cellular biology, 35, 3436-45. doi:10.1128/MCB.00381-15. https://pubmed.ncbi.nlm.nih.gov/26169830/
4. Salgado-Albarrán, Marisol, Späth, Julian, González-Barrios, Rodrigo, Baumbach, Jan, Soto-Reyes, Ernesto. 2022. CTCFL regulates the PI3K-Akt pathway and it is a target for personalized ovarian cancer therapy. In NPJ systems biology and applications, 8, 5. doi:10.1038/s41540-022-00214-z. https://pubmed.ncbi.nlm.nih.gov/35132075/
5. Sati, Leyla, Soygur, Bikem, Goksu, Ethem, Bassorgun, Cumhur Ibrahim, McGrath, James. 2021. CTCFL expression is associated with cerebral vascular abnormalities. In Tissue & cell, 72, 101528. doi:10.1016/j.tice.2021.101528. https://pubmed.ncbi.nlm.nih.gov/33756271/
6. Tong, Xin, Gao, Yang, Su, Zhongjing. 2024. Interaction of CTCF and CTCFL in genome regulation through chromatin architecture during the spermatogenesis and carcinogenesis. In PeerJ, 12, e18240. doi:10.7717/peerj.18240. https://pubmed.ncbi.nlm.nih.gov/39430552/